Genohm and iSpecimen® Partner to Enable their Customers to Seamlessly Connect their Sample Inventories to the iSpecimen Marketplace

LAUSANNE, Switzerland, and LEXINGTON, Mass., Dec. 5, 2017 /PRNewswire/ — Genohm and iSpecimen today jointly announced that Genohm has established a partnership with iSpecimen to enable users of the SLIMS laboratory information management system to seamlessly connect to the iSpecimen Marketplace.

The combined solution will allow Genohm customers to easily make their inventories of biospecimens and associated data available to researchers around the world through the marketplace, and then accept, fulfill and track associated orders for samples. These new capabilities enable Genohm customers to increase revenue as well as the utilization rates of their banked specimens.

The partnership, through the new iSpecimen Data Connector Program, provides Genohm with technology integration support to connect its SLIMS system to the iSpecimen Marketplace and marketing support to promote the joint solution to Genohm’s customers and prospects. Together, the combined solution adds new value to biorepositories and labs that use SLIMS by giving them a new way to spotlight their sample inventories more broadly and earn income from their use.

“Healthcare organizations like Genohm’s customers are doing the hard work of collecting biospecimens, so it should be quick and easy to make their samples available to researchers who need them,” said Christopher Ianelli, MD, PhD, Founder and CEO, iSpecimen. “Although joining the iSpecimen Marketplace has always been easy for specimen suppliers, Genohm’s participation in the iSpecimen Data Connector program makes technology integration virtually automatic.”

Increased specimen utilization will help Genohm customers make a bigger contribution to scientific progress and better fulfill the expectations of biospecimen donors. Meanwhile, researchers will gain quick access to a vast new network of healthcare organizations with hard-to-find, high-quality samples at the ready.

“Many of our clients have built prodigious specimen libraries with great untapped value for themselves and for science,” said Genohm CEO Frederik Decouttere. “The iSpecimen Marketplace Data Connector for SLIMS helps our clients quickly profit from the investments they’ve already made and expand their mission of contributing to scientific advancement.”

About Genohm
Genohm, a Swiss company with headquarters in Lausanne, is the technology leader in both cloud-based and on premise, mission critical, laboratory data automation for research labs, biobanks, diagnostic labs and next-generation sequencing facilities. Genohm delivers a flexible, highly configurable platform built specifically for the needs of these complex lab environments, including sample management, ELN and workflow execution systems that ensure quality, accuracy, compliance and traceability. Genohm’s proprietary SLIMS platform is an industry first at delivering a comprehensive software solution for laboratories that delivers out-of-the-box LIMS+ELN+WORKFLOW solutions for labs with a clear commitment to quality as reflected in a state of the art ISO9001:2015 quality management system. More information about Genohm and SLIMS at or

About iSpecimen
Headquartered in Lexington, MA, iSpecimen is the marketplace for human biospecimens, providing researchers with the specimens they need from the patients they want. The privately held company has developed the iSpecimen Marketplace, an online platform connecting healthcare organizations that have access to patients and specimens with the scientists who need them. Proprietary, cloud-based technology enables researchers to intuitively search for specimens and patients across a federated partner network of hospitals, labs, biobanks, blood centers, and other healthcare organizations. Researchers easily and compliantly gain access to specimens to drive scientific discovery. Partner sites gain an opportunity to contribute to biomedical discovery as well as their bottom line. And ultimately, healthcare advances for all. For more information about iSpecimen, please visit